BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9183597)

  • 1. Evaluation of plasma levels of tumour necrosis factor alpha and interleukin-6 as rejection markers in a cohort of 142 heart-grafted patients followed by endomyocardial biopsy.
    Abdallah AN; Billes MA; Attia Y; Doutremepuich C; Cassaigne A; Iron A
    Eur Heart J; 1997 Jun; 18(6):1024-9. PubMed ID: 9183597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial measurements of interleukin-6, interleukin-8, tumor necrosis factor-alpha, and soluble vascular cell adhesion molecule-1 in the peripheral blood plasma of human cardiac allograft recipients.
    George JF; Kirklin JK; Naftel DC; Bourge RC; White-Williams C; McGiffin DC; Savunen T; Everson MP
    J Heart Lung Transplant; 1997 Oct; 16(10):1046-53. PubMed ID: 9361247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum cytokine levels in heart allograft recipients: correlation with findings on endomyocardial biopsy.
    Jordan SC; Czer L; Toyoda M; Galfayan K; Doan D; Fishbein M; Blanche C; Trento A
    J Heart Lung Transplant; 1993; 12(2):333-7. PubMed ID: 8476907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic validity of hepatocyte growth factor as marker for rejection in the follow-up of patients after heart transplantation.
    Zwirska-Korczala K; Zakliczyński M; Berdowska A; Zembala M; Jochem J; Gajewska K
    J Heart Lung Transplant; 2005 Apr; 24(4):411-5. PubMed ID: 15797741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary sinus sampling of cytokines after heart transplantation: evidence for macrophage activation and interleukin-4 production within the graft.
    Fyfe A; Daly P; Galligan L; Pirc L; Feindel C; Cardella C
    J Am Coll Cardiol; 1993 Jan; 21(1):171-6. PubMed ID: 8417059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semiquantitative measurement of cytokine messenger RNA in endomyocardium and peripheral blood mononuclear cells from human heart transplant recipients.
    Lagoo AS; George JF; Naftel DC; Griffin AK; Kirklin JK; Lagoo-Deenadayalan S; Hardy KJ; Savunen T; McGiffin DC
    J Heart Lung Transplant; 1996 Feb; 15(2):206-17. PubMed ID: 8672525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daily serum inflammatory cytokine (tumor necrosis factor-alpha, interleukin-6) monitoring in liver transplantation focusing on allograft rejection: a five-case report.
    Kita Y; Iwaki Y; Noguchi K; Tzakis AG; Todo S; Fung JJ; Starzl TE
    Transplant Proc; 1996 Jun; 28(3):1237-40. PubMed ID: 8658640
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuroendocrine profiling of humans receiving cardiac allografts.
    Ogawa T; Veinot JP; Davies RA; Haddad H; Smith SJ; Masters RG; Hendry PJ; Starling R; de Bold MK; Ponce A; Ma KK; Williams K; de Bold AJ
    J Heart Lung Transplant; 2005 Aug; 24(8):1046-54. PubMed ID: 16102440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the polymorphism of the tumour necrosis factor (TNF) gene and promoter and of circulating TNF-alpha levels in heart-transplant patients suffering or not suffering from severe rejection.
    Abdallah AN; Cucchi-Mouillot P; Biteau N; Cassaigne A; Haras D; Iron A
    Eur J Immunogenet; 1999 Aug; 26(4):249-55. PubMed ID: 10457886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-skeletal muscle glycolipid antibodies in human heart transplantation as markers of acute rejection. Correlation with endomyocardial biopsy.
    Laguens RP; Argel MI; Chambó JG; Vigliano CA; San Martino JA; Perrone SV; Favaloro RR
    Transplantation; 1996 Jul; 62(2):211-6. PubMed ID: 8755818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial pro-inflammatory cytokine expression and cellular rejection in pediatric heart transplant recipients.
    Breinholt JP; Vallejo JG; Gates CM; Clunie SK; Kearney DL; Dreyer WJ; Towbin JA; Bowles NE
    J Heart Lung Transplant; 2008 Mar; 27(3):317-24. PubMed ID: 18342755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between natriuretic peptides and inflammation: proteomic evidence obtained during acute cellular cardiac allograft rejection in humans.
    Meirovich YF; Veinot JP; de Bold ML; Haddad H; Davies RA; Masters RG; Hendry PJ; de Bold AJ
    J Heart Lung Transplant; 2008 Jan; 27(1):31-7. PubMed ID: 18187084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac troponin T: a noninvasive marker for heart transplant rejection?
    Alexis JD; Lao CD; Selter JG; Courtney MC; Correa DK; Lansman SL; Kushwaha SS; Gass AL
    J Heart Lung Transplant; 1998 Apr; 17(4):395-8. PubMed ID: 9588584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial ultrasensitive CRP measurements may be useful in rejection diagnosis after kidney transplantation.
    Oyen O; Wergeland R; Bentdal O; Hartmann A; Brekke IB; Stokke O
    Transplant Proc; 2001 Jun; 33(4):2481-3. PubMed ID: 11406220
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytokine panel predicts early rejection and therapeutic response after cardiac transplantation.
    Kimball P; Radovancevic B; Isom T; Frazier B; Kerman R
    Transplant Proc; 1995 Feb; 27(1):1286-7. PubMed ID: 7878884
    [No Abstract]   [Full Text] [Related]  

  • 16. Creatine kinase MB isoforms: a potential predictor of acute cardiac allograft rejection.
    Anderson JR; Hossein-Nia M; Brown PA; Corbishley C; Murday AJ; Holt DW
    J Heart Lung Transplant; 1995; 14(4):666-70. PubMed ID: 7578173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin plasma levels in acute graft rejection after heart transplantation.
    Dengler TJ; Zimmermann R; Tiefenbacher CP; Braun K; Sack FU; Kübler W
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1057-64. PubMed ID: 8719451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cytokine messenger RNA after heart transplantation: relationship with rejection and serum cytokines.
    Grant SC; Guy SP; Lamb WR; Brooks NH; Brenchley PE; Hutchinson IV
    Transplantation; 1996 Oct; 62(7):910-6. PubMed ID: 8878383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated levels of serum interleukin-6 are associated with low grade cellular rejection in patients with heart transplantation.
    Perez-Villa F; Benito B; Llancaqueo M; Cuppoletti A; Roig E
    Transplant Proc; 2006 Nov; 38(9):3012-5. PubMed ID: 17112887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relation of interleukin-6, tumor necrosis factor-alpha, IL-2, and IL-2 receptor levels to cellular rejection, allograft dysfunction, and clinical events early after cardiac transplantation.
    Deng MC; Erren M; Kammerling L; Gunther F; Kerber S; Fahrenkamp A; Assmann G; Breithardt G; Scheld HH
    Transplantation; 1995 Nov; 60(10):1118-24. PubMed ID: 7482719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.